Clinical Protocols definition

Clinical Protocols means pre-determined protocols developed by the Participant in accordance with Article 5.5.
Sample 1Sample 2Sample 3
Clinical Protocols means a scientifically tested and medical staff approved method of treatment for diagnostic conditions based on severity of illness, co-morbid circumstances, and symptomatic assessment and evaluation.
Sample 1
Clinical Protocols means a document in which the institutional medical director/supervising Psychiatrist delegates guidelines of medical/Behavioral Health management to a mid-level provider in accordance with TDOC Policy #113.11 as referenced in Appendix B. Clinical Protocols are a formal method established for the management of a disease process or Behavioral Health disorder. Clinical Protocols outline diagnostic tests (including laboratory tests) and treatment for identified health or Behavioral Health conditions and are used under Physician supervision only by professionals with formal advanced training and certification/license in primary health or Behavioral Health care delivery.
Sample 1

Examples of Clinical Protocols in a sentence

  • The UDN Clinical Protocols Working Group developed this Clinical Protocol as part of the Manual of Operations and with input from the UDN Steering Committee will continue to refine it.

  • The Clinical Protocols Working Group currently consists of the members listed below.

  • The decision of which available intervention to offer a TN-T2 Beneficiary will be driven by the EMS service’s specific predetermined Clinical Protocols that have been approved by the EMS service’s medical director.

  • All services/supports authorized in the IPOS must meet the eligibility and medical necessity criteria of the Clinical Protocols, and shall be authorized in accordance with Treatment Authorization Policy 02-001-0015.

  • No. The decision as to what type of EMS response vehicle is to be sent by the TennCare-enrolled ambulance supplier is driven by local system design and the specific predetermined Clinical Protocols and/or other standard operating procedures that have been approved by the EMS service’s medical director.

  • Note: An EMS service must use its Clinical Protocols to make a Triage Decision for any patient identified as a TN-T2 Beneficiary before the EMS service may offer a TN-T2 Intervention to the Beneficiary.

  • Note: It is not possible to edit Biocare Clinical Protocols (protocols provided with the instrument from Biocare) – these protocols can be used directly or as templates for user optimization or copied, renamed and edited for modification.

  • For Clinical Protocols – see section 2.1) A Protocol is the way of prescribing exactly what must be done and documented in a specific situation, often incorporating a number of Procedures.

  • However, applicants are urged to keep this section as brief as possible.Appended materials may include:• Letter from ACS Eligibility Committee confirming eligibility (if applicable)• Letters of support• Recent reprints or preprints (optional)• Clinical Protocols (if applicable) It is not necessary to number the pages of the Appendix, but please list by categories (e.g., reprints, preprints) in the Table of Contents.

  • CONITEC also agreed to elaborate 12 Clinical Protocols and Therapeutic Guidelines for rare disease treatments before the end of 201552.


More Definitions of Clinical Protocols

Clinical Protocols means the clinical protocol methodology for obtaining any Applicable Regulatory Approval for commercialization of any Product from the Applicable Regulatory Authorities. ------------------- * Material has been omitted pursuant to a request for confidential treatment and such material has been filed separately with the Securities and Exchange Commission. Asterisks within brackets denote omissions.
Sample 1
Clinical Protocols means pre-determined protocols developed by SAFD in accordance with Article 5.5.
Sample 1

Related to Clinical Protocols

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Clinical evaluation means a systematic and planned process to continuously generate, collect, analyse and assess the clinical data pertaining to a device in order to verify the safety and performance, including clinical benefits, of the device when used as intended by the manufacturer;

  • Protocols means written directions and orders, consistent with the department’s standard of care, that are to be followed by an emergency medical care provider in emergency and nonemergency situations. Protocols must be approved by the service program’s medical director and address the care of both adult and pediatric patients.

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.

  • MFDA means the Mutual Fund Dealers Association of Canada;

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Quality system means documented organizational procedures and policies: internal audits of those policies and procedures: management review and recommendation for quality improvement.”

  • Step therapy protocol means a protocol or program that establishes the specific

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • ERCOT Protocols means the document adopted by ERCOT, including any attachments or exhibits referenced in that document, as amended from time to time, that contains the scheduling, operating, planning, reliability, and Settlement (including Customer registration) policies, rules, guidelines, procedures, standards, and criteria of ERCOT. For the purposes of determining responsibilities and rights at a given time, the ERCOT Protocols, as amended in accordance with the change procedure(s) described in the ERCOT Protocols, in effect at the time of the performance or non-performance of an action, shall govern with respect to that action.

  • Good Clinical Practices means the FDA’s standards for the design, conduct, performance, monitoring, auditing, recording, analysis, and reporting of clinical trials contained in 21 C.F.R. Part 50, 54, 56, 312, 314, 320, 812, and 814 and (ii) “Good Laboratory Practices” means the FDA’s standards for conducting non-clinical laboratory studies contained in 21 C.F.R. Part 58.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Commercialization Plan has the meaning set forth in Section 6.2.

  • Kyoto Protocol means the protocol to the UNFCCC adopted at the Third Conference of the Parties to the UNFCCC in Kyoto, Japan on 11 December 1997 as may be amended;

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Manufacturing Process means any process for—

  • FDA means the United States Food and Drug Administration and any successor agency thereto.

  • Phase IV Clinical Trial means a product support clinical trial of a Product commenced after receipt of Regulatory Approval in the country where such trial is conducted. A Phase IV Clinical Trial may include epidemiological studies, modeling and pharmacoeconomic studies, and investigator-sponsored clinical trials studying Product that are approved by the JDC and that otherwise fit the foregoing definition.

  • Clinical peer means a physician or other health care professional who holds a non-restricted license in a state of the United States and in the same or similar specialty as typically manages the medical condition, procedure or treatment under review.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Development Plans means a coherent set of operations defined and financed exclusively by the OCTs in the framework of their own policies and strategies of development, and those agreed upon between an OCT and the Member State to which it is linked;

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.